Journey Strategic Wealth’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Buy
14,204
+380
+3% +$7.49K 0.01% 595
2025
Q4
$262K Sell
13,824
-4,655
-25% -$86.3K 0.01% 569
2025
Q3
$344K Buy
18,479
+595
+3% +$11.1K 0.01% 419
2025
Q2
$330K Buy
17,884
+1,252
+8% +$22.2K 0.01% 394
2025
Q1
$291K Buy
+16,632
New +$280K 0.01% 342

Other funds holding SBRA

Journey Strategic Wealth's SBRA Position: Q1 2026 in Review

Journey Strategic Wealth increased its Sabra Healthcare REIT (SBRA) stake by 2.7% in Q1 2026, buying an estimated $7.49K and bringing the position to 14,204 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #595.

Journey Strategic Wealth first reported a position in SBRA in Q1 2025 and has held it in 5 quarters since. The position peaked at $344K in Q3 2025. 462 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Journey Strategic Wealth held 14,204 shares of Sabra Healthcare REIT worth $273K as of Q1 2026.
  • Journey Strategic Wealth bought 380 Sabra Healthcare REIT shares in Q1 2026, an estimated $7.49K.
  • Sabra Healthcare REIT made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #595 holding.
  • Journey Strategic Wealth first reported a position in Sabra Healthcare REIT in Q1 2025 and has held it in 5 quarters since.
  • Journey Strategic Wealth's Sabra Healthcare REIT position peaked at $344K in Q3 2025.
  • 462 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.